A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle by Basma A. Al-Mshhdani, Miranda D. Grounds, Peter G. Arthur, Jessica R. Terrill

Connect to this object online.

Oxidised Albumin Levels in Plasma and Skeletal Muscle as Biomarkers of Disease Progression and Treatment Efficacy in Dystrophic <i>mdx</i> Mice by Jessica R. Terrill, Angelo Patrick R. Bautista, Irene Tsioutsias, Miranda D. Grounds, Peter G. Arthur

Connect to this object online.

Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress by Miranda D. Grounds, Jessica R. Terrill, Basma A. Al-Mshhdani, Marisa N. Duong, Hannah G. Radley-Crabb, Peter G. Arthur

Connect to this object online.

Mouse models for muscular dystrophies: an overview by Maaike van Putten, Erin M. Lloyd, Jessica C. de Greef, Vered Raz, Raffaella Willmann, Miranda D. Grounds, Annemieke Aartsma-Rus, James Dowling, Maaike van Putten

Connect to this object online.

Ageing contributes to phenotype transition in a mouse model of periodic paralysis by Karen J. Suetterlin, S. Veronica Tan, Roope Mannikko, Rahul Phadke, Michael Orford, Simon Eaton, Avan A. Sayer, Miranda D. Grounds, Emma Matthews, Linda Greensmith, Michael G. Hanna

Connect to this object online.

Improving translatability of preclinical studies for neuromuscular disorders: lessons from the TREAT-NMD Advisory Committee for Therapeutics (TACT) by Raffaella Willmann, Joanne Lee, Cathy Turner, Kanneboyina Nagaraju, Annemieke Aartsma-Rus, Dominic J. Wells, Kathryn R. Wagner, Cristina Csimma, Volker Straub, Miranda D. Grounds, Annamaria De Luca, Annemieke Aartsma-Rus, James Dowling, Maaike van Putten

Connect to this object online.